Evidence map›Paper›PMID 33978861›Full record

ArticleCellular and molecular neurobiology2022

Dichotomy in Growth and Invasion from Low- to High-Grade Glioma Cellular Variants.

Krishnendu Ghosh, Samarendranath Ghosh, Uttara Chatterjee, Pritha Bhattacharjee, Anirban Ghosh

Abstract read
In one paragraph

Article in Cellular and molecular neurobiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Connexin-Pannexin duality in glioblastoma.Cell and tissue research · 2026
    Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Krishnendu GhoshImmunobiology Laboratory, Department of Zoology, Panihati Mahavidyalaya, Kolkata, West Bengal, India.ORCID http://orcid.org/0000-0002-8423-3228
Samarendranath GhoshDepartment of Neurosurgery, Bangur Institute of Neurosciences (BIN), Institute of Post Graduate Medical Education and Research (IPGME&R), Kolkata, West Bengal, India.
Uttara ChatterjeeDepartment of Pathology, Institute of Post Graduate Medical Education and Research (IPGME&R), Kolkata, West Bengal, India.ORCID http://orcid.org/0000-0002-9346-1695
Pritha BhattacharjeeEnvironmental Epigenomics Laboratory, Department of Environmental Science, University of Calcutta, Kolkata, West Bengal, India.ORCID http://orcid.org/0000-0002-4623-7746
Anirban GhoshImmunobiology Laboratory, Department of Zoology, Panihati Mahavidyalaya, Kolkata, West Bengal, India. anirbanghosh@wbnsou.ac.in.ORCID http://orcid.org/0000-0001-7349-2622

Funding

Council of Scientific and Industrial Research, INDIA 37(1587)/13/EMR-II
6 · The paper itself

Abstract

Glial dysfunction outraging CNS plasticity and integrity results in one of the most dangerous cancers, namely glioma, featuring little median survival period and high recurrence. The hallmark properties of proliferation, invasion and angiogenesis with the infiltrated macrophages in glioma are expected to be tightly coupled or cross-linked, but not properly related so far. The present study is aimed to find a relationship between this featured quadrangle from lower to higher grades (HG) of post-operative glioma tissues and their invading subsets. Elevated Ki67-associated proliferation in lower grades (LG) was supported with VEGF dependent angiogenic maintenance which found a decrease unlikely in HG. In contrast, MMP 2 and 9-associated invasions augmented high in HG with the dominant presence of CD204

Indexed as

Brain NeoplasmsGliomaHumansMacrophagesNeoplasm InvasivenessNeovascularization, PathologicAngiogenesisDichotomyGAMGliomaInvasionProliferation

Identifiers

PMID33978861
PMCPMC11421645

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.